nodular hyperplasia, non-specific colitis, and pervasive
developmental disorder in children’, The Lancet, 2010.
- Finnegan G., ‘Rise in vaccine hesitancy related to pursuit of
purity’, Horizon Magazine, 26 April 2018; Larson H.J., ‘Maternal
immunization: The new “normal” (or it should be)’, Vaccine, 2015;
Larson H.J. et al., ‘Tracking the global spread of vaccine
sentiments: The global response to Japan’s suspension of its
HPV vaccine recommendation’, Human Vaccines &
Immunotherapeutics, 2014.
- Background on variolation from: ‘Variolation – an overview’,
ScienceDirect Topics, 2018.
- Voltaire., ‘Letter XI’ from Letters on the English. (1734).
- Background on Bernoulli’s work from: Dietz K. and Heesterbeek
J.A.P., ‘Daniel Bernoulli’s epidemiological model revisited’,
Mathematical Biosciences, 2002; Colombo C. and Diamanti M.,
‘The smallpox vaccine: the dispute between Bernoulli and
d’Alembert and the calculus of probabilities’, Lettera Matematica
International, 2015.
- There is a large literature on MMR and measles vaccine safety
and efficacy, e.g. Smeeth L. et al., ‘MMR vaccination and
pervasive developmental disorders: a case-control study’, The
Lancet, 2004; A. Hviid, J.V. Hansen, M. Frisch, et al., ‘Measles,
Mumps, Rubella Vaccination and Autism: A Nationwide Cohort
Study’, Annals of Internal Medicine, 2019; LeBaron C.W. et al.,
‘Persistence of Measles Antibodies After 2 Doses of Measles
Vaccine in a Postelimination Environment’, JAMA Pediatrics,
2007.
- Wellcome Global Monitor 2018, 19 June 2019.
- Finnegan G., ‘Rise in vaccine hesitancy related to pursuit of
purity’, Horizon Magazine, 26 April 2018.
- Funk S. et al., ‘Combining serological and contact data to derive
target immunity levels for achieving and maintaining measles
